Rho2-dependent cell wall remodeling boosts the fungistatic activity of manogepix against <i>Aspergillus fumigatus</i>. [PDF]
Brazil S +4 more
europepmc +1 more source
Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia. [PDF]
Cornely OA +8 more
europepmc +1 more source
Assessment of the molecular identification algorithm and its impact on antifungal susceptibilities against clinical <i>Fusarium</i> isolates: a multicentre study in Taiwan, 2011-2023. [PDF]
Chen PY, Wu CJ, Wu UI, Liu WD, Chen YC.
europepmc +1 more source
Multisystem <i>Lomentospora prolificans</i> progression on fosmanogepix despite <i>in vitro</i> activity: a call for expanding clinical research on novel antifungals. [PDF]
Cooper RA +12 more
europepmc +1 more source
Novel Inositol Acyltransferase (Gwt1) Inhibitor for Fungal Keratitis Treatment: Evaluation of In Vitro and In Vivo Efficacy and Safety. [PDF]
Gowtham L +8 more
europepmc +1 more source
<i>In vitro</i> activity of novel antifungals, natamycin, and terbinafine against <i>Fusarium</i>. [PDF]
Garbe E +5 more
europepmc +1 more source
Emerging antifungal resistance in Candida parapsilosis: the end of the innocence. [PDF]
Guinea J +4 more
europepmc +1 more source
Eumycetoma: pathogenesis, current treatments, and the search for new drugs. [PDF]
Yachioui DE +2 more
europepmc +1 more source
Studying Candida Biofilms Across Species: Experimental Models, Structural Diversity, and Clinical Implications. [PDF]
Squitieri D +6 more
europepmc +1 more source
First report of <i>Candida</i> (<i>Candidozyma) auris</i> infections in a human and a dolphin from the Dominican Republic: A One health perspective. [PDF]
Ferrara GA +5 more
europepmc +1 more source

